原发性血小板增多症-话题@MedSci

#原发性血小板增多症#

10篇内容 | 1490人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2189850, encodeId=53e62189850f8, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a> <a href='/topic/show?id=d8fee046df' target=_blank style='color:#2F92EE;'>#ET#</a>, objectTitle=【AJH】原发性血小板增多症的诊断和治疗（2024）, objectType=article, longId=814994, objectId=b159814994b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-leading-a-medical-team-at-hospital-DQZSHGT.jpg, objectUrl=/article/show_article.do?id=b159814994b8, replyNumber=0, likeNumber=76, createdTime=2024-02-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b159814994b8, moduleTitle=【AJH】原发性血小板增多症的诊断和治疗（2024）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b159814994b8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188253, encodeId=bfb7218825374, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a> <a href='/topic/show?id=c2fa11134623' target=_blank style='color:#2F92EE;'>#非原发性血小板增多症#</a> <a href='/topic/show?id=4e6611134ea6' target=_blank style='color:#2F92EE;'>#血栓栓塞事件#</a>, objectTitle=BJH：原发性血小板增多症和非原发性血小板增多症的血栓栓塞事件、大出血和死亡率, objectType=article, longId=813903, objectId=280e8139036b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221201/1669967618444_4754896.jpeg, objectUrl=/article/show_article.do?id=280e8139036b, replyNumber=0, likeNumber=75, createdTime=2024-02-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=280e8139036b, moduleTitle=BJH：原发性血小板增多症和非原发性血小板增多症的血栓栓塞事件、大出血和死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=280e8139036b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2106355, encodeId=40d42106355bb, content=伴有<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>和<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>的<a href='/topic/show?id=da48522840a' target=_blank style='color:#2F92EE;'>#急性心肌梗死#</a>患者住院预后, objectTitle=JAHA：伴有原发性血小板增多症和真性红细胞增多症的急性心肌梗死患者住院预后, objectType=article, longId=751973, objectId=a791e51973f0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221215/1671072228118_1739456.jpg, objectUrl=/article/show_article.do?id=a791e51973f0, replyNumber=0, likeNumber=140, createdTime=2022-12-16, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a791e51973f0, moduleTitle=JAHA：伴有原发性血小板增多症和真性红细胞增多症的急性心肌梗死患者住院预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a791e51973f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573032, encodeId=1ee615e303294, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=BJH：原发性血小板增多症患者的减细胞治疗及其与血小板功能和成熟度的关系, objectType=article, longId=729556, objectId=ba9fe29556e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba9fe29556e5, replyNumber=0, likeNumber=94, createdTime=2022-06-16, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba9fe29556e5, moduleTitle=BJH：原发性血小板增多症患者的减细胞治疗及其与血小板功能和成熟度的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba9fe29556e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573031, encodeId=ce8015e303174, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症, objectType=article, longId=727286, objectId=b019e27286d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b019e27286d3, replyNumber=0, likeNumber=105, createdTime=2022-05-20, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b019e27286d3, moduleTitle=Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b019e27286d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573030, encodeId=a3e415e30306b, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=Blood：原发性血小板增多症的MPL基因突变揭示了一条依赖于W491的共有激活通路, objectType=article, longId=187109, objectId=ad8918e10955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8918e10955, replyNumber=0, likeNumber=89, createdTime=2020-02-03, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8918e10955, moduleTitle=Blood：原发性血小板增多症的MPL基因突变揭示了一条依赖于W491的共有激活通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad8918e10955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573029, encodeId=c41b15e302956, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=J Clin Oncol:原发性血小板增多症：羟基脲与阿司匹林联用效果如何？, objectType=article, longId=149862, objectId=829b14986267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=829b14986267, replyNumber=0, likeNumber=97, createdTime=2018-09-30, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=829b14986267, moduleTitle=J Clin Oncol:原发性血小板增多症：羟基脲与阿司匹林联用效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=829b14986267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573028, encodeId=b2b015e30287f, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=Blood：卢索替尼治疗对羟基尿素有耐药性的原发性血小板增多症的效果。, objectType=article, longId=108548, objectId=86f610854833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86f610854833, replyNumber=0, likeNumber=101, createdTime=2017-08-13, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86f610854833, moduleTitle=Blood：卢索替尼治疗对羟基尿素有耐药性的原发性血小板增多症的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86f610854833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573027, encodeId=3cd215e302713, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, objectType=article, longId=104445, objectId=f1ee10444578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ee10444578, replyNumber=0, likeNumber=92, createdTime=2017-07-05, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ee10444578, moduleTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1ee10444578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573026, encodeId=2e6915e302662, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=原发性血小板增多症诊断与治疗中国专家共识(2016年版), objectType=article, longId=81729, objectId=ade081e29da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ade081e29da, replyNumber=0, likeNumber=84, createdTime=2016-11-05, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ade081e29da, moduleTitle=原发性血小板增多症诊断与治疗中国专家共识(2016年版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ade081e29da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573025, encodeId=042915e30256a, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=NEJM：端粒酶抑制剂imetelstat用于骨髓纤维化和原发性血小板增多症疗效乐观（2期临床）, objectType=article, longId=55964, objectId=362d559648b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=362d559648b, replyNumber=0, likeNumber=84, createdTime=2015-09-11, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=362d559648b, moduleTitle=NEJM：端粒酶抑制剂imetelstat用于骨髓纤维化和原发性血小板增多症疗效乐观（2期临床）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=362d559648b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573024, encodeId=829315e302417, content=<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>, objectTitle=Cell：单细胞测序新方法研究原发性血小板增多症获进展, objectType=article, longId=4330, objectId=c912433044, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c912433044, replyNumber=0, likeNumber=90, createdTime=2012-03-18, rootId=0, userName=weihongyv, userId=f86c15802806, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c912433044, moduleTitle=Cell：单细胞测序新方法研究原发性血小板增多症获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c912433044)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

原发性血小板增多症

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#原发性血小板增多症# #ET#

【AJH】原发性血小板增多症的诊断和治疗（2024）

2024-02-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#原发性血小板增多症# #非原发性血小板增多症# #血栓栓塞事件#

BJH：原发性血小板增多症和非原发性血小板增多症的血栓栓塞事件、大出血和死亡率

2024-02-20发表于上海

循证小兵 (审核中...)

前往app查看评论内容

伴有#原发性血小板增多症#和#真性红细胞增多症#的#急性心肌梗死#患者住院预后

JAHA：伴有原发性血小板增多症和真性红细胞增多症的急性心肌梗死患者住院预后

2022-12-16发表于上海

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

BJH：原发性血小板增多症患者的减细胞治疗及其与血小板功能和成熟度的关系

2022-06-16

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症

2022-05-20

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

Blood：原发性血小板增多症的MPL基因突变揭示了一条依赖于W491的共有激活通路

2020-02-03

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

J Clin Oncol:原发性血小板增多症：羟基脲与阿司匹林联用效果如何？

2018-09-30

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

Blood：卢索替尼治疗对羟基尿素有耐药性的原发性血小板增多症的效果。

2017-08-13

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！

2017-07-05

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

原发性血小板增多症诊断与治疗中国专家共识(2016年版)

2016-11-05

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

NEJM：端粒酶抑制剂imetelstat用于骨髓纤维化和原发性血小板增多症疗效乐观（2期临床）

2015-09-11

weihongyv (审核中...)

前往app查看评论内容

#原发性血小板增多症#

Cell：单细胞测序新方法研究原发性血小板增多症获进展

2012-03-18

科室
- - 订阅+
  - 更多科室
工具
服务